Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 248-792-9 | CAS number: 28043-10-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1991
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: GLP study following a method equivalent to a recognised guideline; minor deviation - rechallenge conducted 24h after first challenge; to account for the movement of occlusive dressing.
- Remarks:
- Expert assessment indicates this is not considered a significant deviation: may increase the response rate due to irritation-mediated effects resulting from a lack of rest period between dose applications. Results in a predisposition towards positive dermal responses in rechallenge considering vehicle and method of application.
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 992
- Report date:
- 1992
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- yes
- Remarks:
- Rechallenge conducted 24h after first challenge; to account for the movement of occlusive dressing. Not considered a significant deviation: may increase the response rate due to irritation-mediated effects from lack of rest period between dose application
- Principles of method if other than guideline:
- Method employed in this study for the detection of delayed contact hypersensitivity was the guinea-pig maximization test described by B. Magnusson and A.M. Kligman (1970) in "Allergic Contact Dermatitis in the Guinea-Pig: Identification of contact allergens"; C.C. Thomas, USA.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- inspected June 1990 ; signature: October 1990
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- The test was conducted prior to 11 October 2016 as stated under Commission Regulation (EU) 2017/706 and is used by read-across adaptation under Regulation (EC) 1907/2006: Annex XI: section 1.5 read-across.
Test material
- Reference substance name:
- -
- EC Number:
- 432-350-9
- EC Name:
- -
- Cas Number:
- 81752-87-6
- Molecular formula:
- C11H18O2
- IUPAC Name:
- methyl 2,2-dimethyl-6-methylidenecyclohexanecarboxylate
- Test material form:
- other: liquid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Recognised supplier
- Housing: group housed (groups of 10) in stainless steel cages.
- Diet (e.g. ad libitum): FD1, SQC ad libitum; certificate of analysis documented
- Water (e.g. ad libitum): tap water ad libitum; certificate of analysis documented
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 22°C; air conditioned
- Humidity (%): 52 - 66 %
- Air changes (per hr): Not reported.
- Photoperiod (hrs dark / hrs light): 12 hours light/12 hours dark
IN-LIFE DATES: From: 24 July 1991 To: 26 August 1991
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- other: 'light liquid paraffin' (intradermal injection) and ethanol for topical induction booster and/or challenge
- Concentration / amount:
- Preliminary irritation testing: intradermal: 100% (undiluted),50, 25, 5 and 1% v/v; topical: 100% (undiluted), 50, 25 and 12.5% v/v in ethanol
25% in light paraffin was chosen for intradermal induction (highest acceptable localised response concentration; non-irritating)
100% was found to be highest non-irritant topical induction. 50% in ethanol was selected for challenge concentrations
Main study conditions:
Induction:
- Intradermal: 25% test material in light liquid paraffin
- Topical: 100% test material (undiluted) in ethanol
- Challenge: 50% in ethanol
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: 'light liquid paraffin' (intradermal injection) and ethanol for topical induction booster and/or challenge
- Concentration / amount:
- Preliminary irritation testing: intradermal: 100% (undiluted),50, 25, 5 and 1% v/v; topical: 100% (undiluted), 50, 25 and 12.5% v/v in ethanol
25% in light paraffin was chosen for intradermal induction (highest acceptable localised response concentration; non-irritating)
100% was found to be highest non-irritant topical induction. 50% in ethanol was selected for challenge concentrations
Main study conditions:
Induction:
- Intradermal: 25% test material in light liquid paraffin
- Topical: 100% test material (undiluted) in ethanol
- Challenge: 50% in ethanol
- No. of animals per dose:
- Test group: 20; Control group: 10
- Details on study design:
- RANGE FINDING TESTS:
Preliminary Investigations: An intradermal injection concentration ranging study was performed to determine a suitable concentration of the test item for the intradermal induction stage of the main study. 0.1 ml aliquots of undiluted test article and 50%, 25%, 10%, 5%, and 1% v/v concentrations of the test article in light liquid paraffin were injected intradermally into the flanks of one guinea pig. Observations made daily for 6 days and the response at each injection site noted. A 25% v/v concentration test article was chosen for the main intradermal injection stage, this being the highest concentration caused an acceptable localised response during the observation period. In the topical range finding study the maximum non-irritating concentration and the minimum irritant concentration of the test item was determined with an ethanol vehicle using organisms previously treated with Freund's Complete Adjuvant. Four concentrations of the test item were used. These were undiluted test article and 50%, 25% and 12.5% v/v concentrations of the supplied test article in ethanol.
MAIN STUDY
A. INDUCTION EXPOSURE
Intradermal induction: intradermal injections of 0.1ml pairs of injections of the following were made: 50% aqueous Complete Freund's Adjuvant alone, 25% v/v test item in light liquid paraffin and undiluted test item with equal volume of FCA in distilled water and with final test item concentration 25% v/v were injected into the clipped area dorsal area of each of 20 guinea pigs. The control group similarly received 50% v/v FCA in distilled water. Light liquid paraffin vehicle only. Then light liquid paraffin with equal volume of FCA in distilled water.
Topical Application: Seven days after intradermal injections, the topical induction phase was conducted. Prior to the topical induction, the injection sites were clipped free of hair. 0.4 ml of the test item undiluted were attached at the injection sites using an occlusive dressing. The control groups were similarly treated. The dressing was left in place for 48 hours.
B. CHALLENGE EXPOSURE
14 days after the induction period, the fur was clipped and the test item undiluted (0.1 ml) was applied to a 2 x 2 cm Whatman No, 3 MM paper in a similar fashion to that used for topical induction application. The right flank was treated with 50% v/v in ethanol similarly with occlusive dressing for 24 hours. On removing the dressings, 24 hours later, it was noted that on 11 animals the patches used for application of the undiluted test article had become detached from the intended application sites. At this stage it was decided to proceed with the assessment of all application sites, at 24 and 48 hour intervals, after removal of the dressings and then perform a second challenge.
A second challenge was performed 24 hours after completion of the first challenge. Approximately 3 hours after application patches were again observed being dislodged from beneath the occlusive dressings. In an attempt to remedy this all patches and dressings were removed and fresh patches applied and secured with additional lengths of adhesive bandage. These patches remained in position for the required 24 hours. After removal of the patches and dressings the application sites were assessed in the same manner as the first challenge.
The scoring system for responses was fully described within the study report. - Positive control substance(s):
- no
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- other: rechallenge 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100%
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: rechallenge 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100%. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- other: rechallenge 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: rechallenge 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 20.0.
- Reading:
- other: rechallenge 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: rechallenge 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100. No with. + reactions: 0.0. Total no. in groups: 20.0.
- Reading:
- other: rechallenge 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 50%
- No. with + reactions:
- 2
- Total no. in group:
- 20
- Remarks on result:
- other: Reading: other: rechallenge 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 50%. No with. + reactions: 2.0. Total no. in groups: 20.0.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 24.0. Group: negative control. Dose level: 0. No with. + reactions: 0.0. Total no. in groups: 10.0.
- Reading:
- rechallenge
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 0%
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: rechallenge. . Hours after challenge: 48.0. Group: negative control. Dose level: 0%. No with. + reactions: 0.0. Total no. in groups: 10.0.
Any other information on results incl. tables
All organisms gained body weight during the course of the study. There were no reports of any clinical signs. All responses were limited to score 1 during rechallenge only and the response rate was 10% in the 50%v/v rechallenge only. No responses were seen in the 100% v/v (undiluted) challenge or rechallenge.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study used, the test material is not considered to be a contact sensitizer.
- Executive summary:
The study was performed according to a method equivalent to guideline OECD TG 406 consistent with Magnusson-Kligman maximisation test to assess the skin sensitisation potential of the test substance. The study was conducted using a preliminary irritation screen, a two-stage induction phase and a challenge phase with a rechallenge. Preliminary irritation testing was used to define the doses in the induction phases of the study and the challenge phase of the study. The first stage of the induction phase involved intradermal injections of 0.1ml pairs of injections of: 50% aqueous Complete Freund's Adjuvant alone, 25% v/v test item in light liquid paraffin and undiluted test item with equal volume of FCA in distilled water and with final test item concentration 25% v/v were injected into the clipped area dorsal area of each of 20 guinea pigs. The control group similarly received 50% v/v FCA in distilled water. Light liquid paraffin vehicle only. Then light liquid paraffin with equal volume of FCA in distilled water. After 7 days the second stage of the induction phase entailed the topical application of 0.4 ml of the test item undiluted attached at the injection sites using an occlusive dressing. The control groups were similarly treated. The dressing was left in place for 48 hours. 14 days after the induction period, a challenge dose of the undiluted test substance selected for application to the left flank on each test animal; and 50% v/v in ethanol applied to the right flank using the same procedure as in the topical induction. The site was inspected at 24 and 48 hours and due to dislodging of the application patches beneath the occlusive dressing a rechallenge was initiated 24hours after the first challenge. Again 3 hours into the second challenge dislodging occurred and so fresh application patches applied. Following the first challenge application no response was observed at either challenge dose. The overall sensitisation rate was 0%. No responses were exhibited in any member of the test group (undiluted, 100% v/v) or control group. Following the second challenge using 50%v/v concentration in the test group two responses were exhibited (scored 1). No responses were seen in the control group. The overall sensitisation rate was 10%. Since the overall response rate both in the challenge and rechallenge was < 30 %, under the conditions of this study the test substance is not a contact skin sensitizer.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.